Javascript must be enabled to continue!
Comparison of oral versus vaginal misoprostol for medical management of early fetal demise at Akhtar Saeed Trust Hospital, Lahore.
View through CrossRef
Objective: To compare the efficacy, safety, and clinical outcomes of oral versus vaginal misoprostol for medical management of first-trimester missed abortion at Akhtar Saeed Trust Hospital, Lahore. Study Design: Randomized Controlled Trial. Setting: Akhtar Saeed Trust Hospital, Lahore. Period: 15 November 2024 to 15 February 2025. Methods: A total of 110 female patients aged 18–45 years with a confirmed diagnosis of first-trimester missed abortion (gestational age <14 weeks) were enrolled. Participants were randomly assigned into two groups: Group A received oral misoprostol (400μg every six hours, up to three doses), and Group B received vaginal misoprostol (400μg soaked in normal saline, every six hours, up to three doses). Primary outcomes included treatment efficacy (complete uterine evacuation within 24 hours) and the need for surgical evacuation. Secondary outcomes included the mean time to expulsion and adverse effects such as bleeding, pain, vomiting, fever, and diarrhea. Data were analyzed using SPSS version 25.0, with a chi-square test used to compare efficacy between groups. Results: The efficacy of vaginal misoprostol (93.1%) was significantly higher than oral misoprostol (75.0%) (p=0.009). The mean time to expulsion was shorter in the vaginal group (10.87±2.0 hours) compared to the oral group (13.24±2.0 hours). The need for surgical evacuation was significantly higher in the oral group (25.0%) than in the vaginal group (6.9%) (p=0.009). Adverse effects, including bleeding, abdominal pain, vomiting, fever, and diarrhea, were comparable between groups, with no statistically significant differences. Conclusion: Vaginal misoprostol is more effective, results in faster expulsion, and significantly reduces the need for surgical evacuation compared to oral misoprostol. Given its superior clinical outcomes, vaginal misoprostol should be considered the preferred method for the medical management of first-trimester missed abortion.
Independent Medical Trust
Title: Comparison of oral versus vaginal misoprostol for medical management of early fetal demise at Akhtar Saeed Trust Hospital, Lahore.
Description:
Objective: To compare the efficacy, safety, and clinical outcomes of oral versus vaginal misoprostol for medical management of first-trimester missed abortion at Akhtar Saeed Trust Hospital, Lahore.
Study Design: Randomized Controlled Trial.
Setting: Akhtar Saeed Trust Hospital, Lahore.
Period: 15 November 2024 to 15 February 2025.
Methods: A total of 110 female patients aged 18–45 years with a confirmed diagnosis of first-trimester missed abortion (gestational age <14 weeks) were enrolled.
Participants were randomly assigned into two groups: Group A received oral misoprostol (400μg every six hours, up to three doses), and Group B received vaginal misoprostol (400μg soaked in normal saline, every six hours, up to three doses).
Primary outcomes included treatment efficacy (complete uterine evacuation within 24 hours) and the need for surgical evacuation.
Secondary outcomes included the mean time to expulsion and adverse effects such as bleeding, pain, vomiting, fever, and diarrhea.
Data were analyzed using SPSS version 25.
0, with a chi-square test used to compare efficacy between groups.
Results: The efficacy of vaginal misoprostol (93.
1%) was significantly higher than oral misoprostol (75.
0%) (p=0.
009).
The mean time to expulsion was shorter in the vaginal group (10.
87±2.
0 hours) compared to the oral group (13.
24±2.
0 hours).
The need for surgical evacuation was significantly higher in the oral group (25.
0%) than in the vaginal group (6.
9%) (p=0.
009).
Adverse effects, including bleeding, abdominal pain, vomiting, fever, and diarrhea, were comparable between groups, with no statistically significant differences.
Conclusion: Vaginal misoprostol is more effective, results in faster expulsion, and significantly reduces the need for surgical evacuation compared to oral misoprostol.
Given its superior clinical outcomes, vaginal misoprostol should be considered the preferred method for the medical management of first-trimester missed abortion.
Related Results
Potentially acute misoprostol toxicity during third-trimester pregnancy: a case report
Potentially acute misoprostol toxicity during third-trimester pregnancy: a case report
Background: The International Federation of Gynecology and Obstetrics (FIGO) recommends the dosage of misoprostol for pregnancy termination in >28 weeks is 25 mcg to 100 mcg per...
Obat Aborsi Bandung | WA : 0858 6506 9949 | Obat Penggugur Kandungan Bandung | Obat Telat Bulan Bandung | Obat Cytotec Bandung | Obat Pelancar Haid Bandung
Obat Aborsi Bandung | WA : 0858 6506 9949 | Obat Penggugur Kandungan Bandung | Obat Telat Bulan Bandung | Obat Cytotec Bandung | Obat Pelancar Haid Bandung
Jual Obat Aborsi Bandung | Obat Penggugur kandungan Bandung | Pil Aborsi Janin Bandung | Obat Pil Penggugur Kandungan Bandung | Alamat Klinik Jual Obat Aborsi Bandung | Apotik Jual...
Efficacy of oral versus vaginal misoprostol in the management of first trimester incomplete miscarriage.
Efficacy of oral versus vaginal misoprostol in the management of first trimester incomplete miscarriage.
Objective: To compare the efficacy of oral versus vaginal misoprostol in first trimester incomplete miscarriage. Study Design: Cross-sectional study. Setting: Gynae B Unit of Lady ...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Comparison of Mifepristone plus Misoprostol with Misoprostol Alone for First Trimester Medical Abortion: A Systematic Review & Meta -Analysis Protocol
Comparison of Mifepristone plus Misoprostol with Misoprostol Alone for First Trimester Medical Abortion: A Systematic Review & Meta -Analysis Protocol
Abstract
Background Original clinical trials have demonstrated that the combined mifepristone plus misoprostol has a marked effectiveness on first trimester abortion practi...
Efficacy of Single Dose of 800µg Vaginal Misoprostol in the Induction of First Trimester Abortion
Efficacy of Single Dose of 800µg Vaginal Misoprostol in the Induction of First Trimester Abortion
Background: Dissolution of pregnancy in the first trimester for several maternal as well as foetal concerns (therapeutic abortion) is a common obstetrical issue. However, induction...
Misoprostol use in medical evacuation of spontaneous miscarriage: Pilot drug use evaluation study at the Women's Hospital in Qatar
Misoprostol use in medical evacuation of spontaneous miscarriage: Pilot drug use evaluation study at the Women's Hospital in Qatar
Background: Misoprostol is a synthetic prostaglandin E1 that induces cervical effacement and uterine contractions at all gestational ages, thus facilitating uterine evacuation and ...
Comparative Study of Sublingual versus Rectal Route of Misoprostol Administration in Prevention of Primary Post-partum Haemorrhage in Women with Risk Factors in ESUT Teaching Hospital, Enugu, Nigeria
Comparative Study of Sublingual versus Rectal Route of Misoprostol Administration in Prevention of Primary Post-partum Haemorrhage in Women with Risk Factors in ESUT Teaching Hospital, Enugu, Nigeria
Background: Post-partum haemorrhage is a major cause of maternal death globally but more in low-income countries. While various studies recognized the efficacy of misoprostol in de...

